MARKET

PSNL

PSNL

Personalis
NASDAQ
12.87
+0.28
+2.22%
Opening 14:05 06/26 EDT
OPEN
12.50
PREV CLOSE
12.59
HIGH
13.37
LOW
12.26
VOLUME
2.73M
TURNOVER
--
52 WEEK HIGH
13.37
52 WEEK LOW
3.840
MARKET CAP
1.35B
P/E (TTM)
-12.6561
1D
5D
1M
3M
1Y
5Y
1D
Merck's Bio-Techne buyout put Life Sciences sector in focus: top quant-rated stocks
Seeking Alpha · 1d ago
Weekly Report: what happened at PSNL last week (0615-0619)?
Weekly Report · 4d ago
Weekly Report: what happened at PSNL last week (0608-0612)?
Weekly Report · 06/15 10:22
Caris Life Sciences: The Discount To Peers Looks Hard To Ignore
Seeking Alpha · 06/12 11:57
Personalis’ specimen collection kits obtain European Union CE-IVD mark
TipRanks · 06/09 10:45
Personalis Wins EU Compliance Mark for Cancer Testing Blood Kits, Blood Collection Kits Receive European Diagnostic Mark
Benzinga · 06/09 10:06
Personalis blood collection kits win EU CE-IVD mark under IVDR
PUBT · 06/09 10:00
Personalis Enables Global Biopharma Support with CE-IVD Marked Specimen Collection Kits
Barchart · 06/09 05:00
More
About PSNL
Personalis, Inc. is engaged in developing, marketing and selling advanced cancer genomic tests and analytics. The Company’s advanced genomic sequencing and analytics support the development of personalized cancer vaccines and other cancer immunotherapies. Its products include NeXT Personal, ImmunoI DNeXT, NeXT Personal Dx, NeXT Dx, whole exome sequencing (WES), and whole genome sequencing (WGS). NeXT Personal is a tumor-informed liquid biopsy test for the detection of minimal residual disease (MRD) and recurrence in cancer. NeXT Dx is a comprehensive tumor profiling test that is used to help select therapy for a cancer patient and identify potential clinical trials for a patient. The Company performed WGS on human samples for research projects, such as population sequencing initiatives. The Company’s tests and analytics are used by pharmaceutical companies for translational research, biomarker discovery, and the development of personalized cancer therapies.

Webull offers Personalis Inc stock information, including NASDAQ: PSNL real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PSNL stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading PSNL stock methods without spending real money on the virtual paper trading platform.